Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anus Neoplasms × Taxes × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 39 Pancreatic Neoplasms 32 Carcinoma, Non-Small-Cell Lung 32 Triple Negative Breast Neoplasms 23 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 11 Lung Neoplasms 11 Melanoma 6 Breast Neoplasms, Male 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Cholangiocarcinoma 5 Inflammatory Breast Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Transitional Cell 4 Brenner Tumor 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Pleural Effusion, Malignant 3 Pancreatic Adenocarcinoma 3 Neoplasms 3 Nasopharyngeal Carcinoma 3 Endometrial Neoplasms 3 Advanced Pancreatic Cancer 3 Adenocarcinoma 3 Uveal Melanoma 2 Thymoma 2

Interventions

Fluorouracil 11 Cisplatin 6 Capecitabine 5 pembrolizumab 4 dehydroftorafur 4 Specimen Handling 4 Radiotherapy 4 Radiation 4 Mitomycin 4 Paclitaxel 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Drug Therapy 3 Cetuximab 3 Carboplatin 3 Biopsy 3 Radiotherapy, Intensity-Modulated 2 Platinum 2 Mitozytrex 2 Fluorodeoxyglucose F18 2 1,2-diaminocyclohexaneplatinum II citrate 2 toripalimab 1 tislelizumab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 durvalumab 1 avelumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡